Arlington Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $231K | Sell |
1,809
-40
| -2% | -$4.99K | 0.03% | 90 |
|
|
2025
Q4 | $225K | Buy |
+1,849
| New | +$212K | 0.03% | 98 |
|
|
2025
Q2 | – | Sell |
-22,685
| Closed | -$1.84M | – | 112 |
|
|
2025
Q1 | $1.84M | Buy |
22,685
+181
| +0.8% | +$16.2K | 0.32% | 51 |
|
|
2024
Q4 | $2.03M | Sell |
22,504
-21,216
| -49% | -$2.06M | 0.4% | 46 |
|
|
2024
Q3 | $4.32M | Buy |
43,720
+1,101
| +3% | +$108K | 0.89% | 31 |
|
|
2024
Q2 | $3.95M | Buy |
42,619
+836
| +2% | +$75K | 0.87% | 29 |
|
|
2024
Q1 | $3.96M | Buy |
41,783
+27,920
| +201% | +$2.59M | 0.87% | 33 |
|
|
2023
Q4 | $1.24M | Sell |
13,863
-29,389
| -68% | -$2.18M | 0.37% | 50 |
|
|
2023
Q3 | $3.16M | Buy |
43,252
+436
| +1% | +$34.8K | 1.12% | 29 |
|
|
2023
Q2 | $3.56M | Buy |
42,816
+556
| +1% | +$46.5K | 1.3% | 21 |
|
|
2023
Q1 | $3.22M | Buy |
42,260
+1,551
| +4% | +$129K | 1.24% | 24 |
|
|
2022
Q4 | $3.38M | Buy |
40,709
+1,931
| +5% | +$156K | 1.42% | 20 |
|
|
2022
Q3 | $3.08M | Sell |
38,778
-2,097
| -5% | -$177K | 1.56% | 18 |
|
|
2022
Q2 | $3.04M | Buy |
40,875
+2,325
| +6% | +$175K | 1.36% | 23 |
|
|
2022
Q1 | $3.46M | Buy |
38,550
+12,047
| +45% | +$1.11M | 1.31% | 24 |
|
|
2021
Q4 | $2.97M | Sell |
26,503
-3,051
| -10% | -$368K | 1% | 33 |
|
|
2021
Q3 | $3.71M | Buy |
29,554
+335
| +1% | +$43.1K | 1.45% | 22 |
|
|
2021
Q2 | $3.96M | Buy |
29,219
+2,936
| +11% | +$386K | 1.5% | 19 |
|
|
2021
Q1 | $3.56M | Buy |
26,283
+45
| +0.2% | +$6.74K | 1.45% | 21 |
|
|
2020
Q4 | $3.69M | Buy |
26,238
+459
| +2% | +$58.8K | 1.56% | 19 |
|
|
2020
Q3 | $2.87M | Sell |
25,779
-3,629
| -12% | -$407K | 1.47% | 20 |
|
|
2020
Q2 | $3.29M | Sell |
29,408
-338
| -1% | -$33.3K | 1.86% | 16 |
|
|
2020
Q1 | $2.3M | Buy |
29,746
+1,553
| +6% | +$138K | 1.64% | 18 |
|
|
2019
Q4 | $2.68M | Buy |
28,193
+627
| +2% | +$54.2K | 1.49% | 22 |
|
|
2019
Q3 | $2.1M | Buy |
27,566
+740
| +3% | +$61.5K | 1.2% | 28 |
|
|
2019
Q2 | $2.35M | Buy |
26,826
+695
| +3% | +$59.3K | 1.35% | 26 |
|
|
2019
Q1 | $2.37M | Buy |
26,131
+5,215
| +25% | +$444K | 1.34% | 26 |
|
|
2018
Q4 | $1.5M | Sell |
20,916
-2,235
| -10% | -$180K | 0.64% | 47 |
|
|
2018
Q3 | $1.87M | Buy |
23,151
+74
| +0.3% | +$7.17K | 1.12% | 29 |
|
|
2018
Q2 | $2.2M | Buy |
23,077
+513
| +2% | +$47.1K | 1.28% | 26 |
|
|
2018
Q1 | $2.02M | Sell |
22,564
-1,721
| -7% | -$157K | 1.33% | 21 |
|
|
2017
Q4 | $2.32M | Buy |
+24,285
| New | +$2.03M | 1.09% | 23 |
|
Other funds holding XBI
